PATENT CLAIM ANALYSIS

Application Number: 16090726
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "005200"]

Abstract:
Neuropeptide S receptor agonists are provided. The NPS agonists include peptidomimetic analogs exhibiting affinity for and activity at the neuropeptide S receptor. The molecules may be useful in the treatment of disorders, syndromes and conditions mediated by modulation of the neuropeptide S receptor such as substance abuse, narcolepsy, insomnia, obesity, cognitive decline, dementia, Alzheimer's disease, panic disorder, generalized anxiety, PTSD, phobias, schizophrenia and as supportive medication during any kind of cessation program in cognitive behavioral therapy, such as drug addiction, eating disorders and gambling.

Claim (Index 20):
The method of  claim 19 , further comprising administering an effective amount of a second therapeutically effective agent.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.52239
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15475227', '11018049', '15465218', '10799324', '11933056']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7445968572634977
- 35 USC 102 Novelty (BERT): 0.5054168847155011
- Combined Prediction Score: 0.720678860008698
- Mean Citation Score: 204.930786
- Max Citation Score: 207.6844
- Similarity Product: 121.77137072174548

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test